Drugs & Targets Darzalex Faspro receives accelerated approval from FDA for newly diagnosed light chain amyloidosis January 22, 2021Vol.47 No.03
Drugs & Targets FDA grants Priority Review to Opdivo as adjuvant therapy resected esophageal or gastroesophageal junction cancer January 22, 2021Vol.47 No.03
Drugs & Targets FDA grants Priority Review to Opdivo + chemotherapy as first-line treatment in metastatic gastric cancer, GEJC and EAC January 22, 2021Vol.47 No.03
Drugs & Targets FDA updates vinca alkaloid labeling for preparation in intravenous infusion bags only January 22, 2021Vol.47 No.03
Clinical Roundup Cancer-related suicide declined in the U.S. during the past two decades January 22, 2021Vol.47 No.03
Clinical Roundup Pre-surgery chemotherapy is possible for early stage pancreatic cancer patients January 22, 2021Vol.47 No.03
Clinical Roundup Study defines small-cell lung cancer subtypes and distinct therapeutic vulnerabilities January 22, 2021Vol.47 No.03
Clinical Roundup GCI study of gynecologic cancers in Brazil finds most patients present with advanced disease January 22, 2021Vol.47 No.03
Funding Opportunities SU2C announces $3.25 million in grants for head and neck cancer research January 22, 2021Vol.47 No.03
In Brief Adekunle Odunsi named director of UChicago Medicine Comprehensive Cancer Center January 22, 2021Vol.47 No.03
